Want to see HK:0919 full AI Analyst Report?
Modern Healthcare Technology Holdings Limited (0919) Ratios
Modern Healthcare Technology Holdings Limited Ratios
HK:0919's free cash flow for Q4 2025 was $34.78M. For the 2025 fiscal year, HK:0919's free cash flow was decreased by $-959.00K and operating cash flow was $35.73M. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.24 | 1.04 | 1.01 | 1.11 | 1.06 |
| Quick Ratio | 1.21 | 1.00 | 0.98 | 1.09 | 1.04 |
| Cash Ratio | 0.99 | 0.63 | 0.52 | 0.50 | 0.36 |
| Solvency Ratio | 0.22 | 0.19 | 0.16 | 0.19 | 0.06 |
| Operating Cash Flow Ratio | 0.27 | 0.43 | 0.22 | 0.41 | 0.15 |
| Short-Term Operating Cash Flow Coverage | 3.38 | 425.60 | 131.75 | -0.58 | -0.25 |
| Net Current Asset Value | $ 46.27M | $ -7.19M | $ -53.36M | $ 24.42M | $ 11.96M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.12 | 0.17 | 0.07 | 0.11 |
| Debt-to-Equity Ratio | 0.23 | 0.37 | 0.56 | 0.20 | 0.30 |
| Debt-to-Capital Ratio | 0.19 | 0.27 | 0.36 | 0.17 | 0.23 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.79 | 3.04 | 3.23 | 2.81 | 2.60 |
| Debt Service Coverage Ratio | 2.14 | 2.54 | 3.31 | -0.31 | -0.13 |
| Interest Coverage Ratio | 1.26 | 0.07 | 0.33 | -0.51 | -3.67 |
| Debt to Market Cap | 0.28 | 0.01 | 0.01 | -1.64 | -1.68 |
| Interest Debt Per Share | 0.08 | 0.11 | 0.15 | 0.07 | 0.09 |
| Net Debt to EBITDA | -2.37 | -1.99 | -0.85 | -1.86 | -2.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.75% | 36.46% | 36.72% | 97.14% | 96.04% |
| EBIT Margin | 7.51% | 0.32% | 4.19% | -4.06% | -18.16% |
| EBITDA Margin | 24.43% | 17.01% | 21.04% | 17.40% | 7.42% |
| Operating Profit Margin | 7.51% | 0.47% | 2.08% | -2.93% | -20.32% |
| Pretax Profit Margin | 0.08% | -0.67% | -2.11% | -4.50% | -18.75% |
| Net Profit Margin | -0.40% | -1.12% | -2.10% | -5.07% | -19.35% |
| Continuous Operations Profit Margin | -0.12% | -1.05% | -1.90% | -4.95% | -19.32% |
| Net Income Per EBT | -469.87% | 166.64% | 99.82% | 112.69% | 103.22% |
| EBT Per EBIT | 1.13% | -144.14% | -101.34% | 153.45% | 92.27% |
| Return on Assets (ROA) | -0.34% | -0.90% | -1.57% | -3.67% | -12.05% |
| Return on Equity (ROE) | -0.94% | -2.73% | -5.06% | -10.32% | -31.34% |
| Return on Capital Employed (ROCE) | 15.12% | 0.99% | 3.79% | -5.45% | -31.09% |
| Return on Invested Capital (ROIC) | -19.00% | 0.80% | 2.78% | -640.01% | -85.34% |
| Return on Tangible Assets | -0.34% | -0.90% | -1.57% | -3.40% | -11.07% |
| Earnings Yield | -2.09% | -7.57% | -12.30% | -13.89% | -56.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 13.41 | 7.18 | 3.39 | 3.37 | 2.49 |
| Payables Turnover | 260.14 | 272.74 | 217.49 | 8.77 | 53.49 |
| Inventory Turnover | 34.40 | 22.61 | 34.29 | 1.48 | 1.80 |
| Fixed Asset Turnover | 4.14 | 2.83 | 2.32 | 3.15 | 2.36 |
| Asset Turnover | 0.85 | 0.80 | 0.74 | 0.72 | 0.62 |
| Working Capital Turnover Ratio | 10.20 | 56.97 | 21.90 | 13.42 | 4.20 |
| Cash Conversion Cycle | 36.43 | 65.63 | 116.56 | 312.60 | 343.03 |
| Days of Sales Outstanding | 27.22 | 50.82 | 107.60 | 108.29 | 146.64 |
| Days of Inventory Outstanding | 10.61 | 16.15 | 10.64 | 245.92 | 203.22 |
| Days of Payables Outstanding | 1.40 | 1.34 | 1.68 | 41.61 | 6.82 |
| Operating Cycle | 37.83 | 66.97 | 118.24 | 354.21 | 349.86 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.09 | 0.17 | 0.09 | 0.15 | 0.06 |
| Free Cash Flow Per Share | 0.09 | 0.15 | 0.07 | 0.14 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | 26.14 | 9.36 | 5.39 | 9.78 | 0.63 |
| Capital Expenditure Coverage Ratio | 26.14 | 9.36 | 5.39 | 9.78 | 0.63 |
| Operating Cash Flow Coverage Ratio | 1.84 | 2.20 | 0.74 | 3.49 | 0.79 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.33 | 0.17 | 0.34 | 0.14 |
| Free Cash Flow Yield | 91.61% | 201.61% | 82.37% | 84.62% | -24.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -46.50 | -13.21 | -8.13 | -7.20 | -1.76 |
| Price-to-Sales (P/S) Ratio | 0.19 | 0.15 | 0.17 | 0.37 | 0.34 |
| Price-to-Book (P/B) Ratio | 0.45 | 0.36 | 0.41 | 0.74 | 0.55 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 1.09 | 0.50 | 1.21 | 1.18 | -4.10 |
| Price-to-Operating Cash Flow Ratio | 1.05 | 0.44 | 0.99 | 1.06 | 2.36 |
| Price-to-Earnings Growth (PEG) Ratio | 0.72 | 0.28 | 0.15 | 0.10 | 0.01 |
| Enterprise Value Multiple | -1.59 | -1.13 | -0.04 | 0.23 | 2.43 |
| Enterprise Value | -171.76M | -86.76M | -3.62M | 16.54M | 64.17M |
| EV to EBITDA | -1.59 | -1.13 | -0.04 | 0.23 | 2.43 |
| EV to Sales | -0.39 | -0.19 | -0.01 | 0.04 | 0.18 |
| EV to Free Cash Flow | -2.23 | -0.64 | -0.06 | 0.13 | -2.17 |
| EV to Operating Cash Flow | -2.14 | -0.57 | -0.05 | 0.12 | 1.25 |
| Tangible Book Value Per Share | 0.21 | 0.21 | 0.21 | 0.23 | 0.25 |
| Shareholders’ Equity Per Share | 0.21 | 0.21 | 0.21 | 0.22 | 0.24 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 2.39 | -0.57 | 0.10 | -0.10 | -0.03 |
| Revenue Per Share | 0.49 | 0.50 | 0.50 | 0.45 | 0.39 |
| Net Income Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.08 |
| Tax Burden | -4.70 | 1.67 | 1.00 | 1.13 | 1.03 |
| Interest Burden | 0.01 | -2.13 | -0.50 | 1.11 | 1.03 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.04 | 0.04 | 0.07 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -45.47 | -49.70 | -8.22 | -7.65 | -0.77 |
Currency in HKD